These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 31348125)
1. The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) Administration. Li G; Sachdev U; Peters K; Liang X; Lotze MT J Immunother; 2019 Sep; 42(7):237-243. PubMed ID: 31348125 [TBL] [Abstract][Full Text] [Related]
2. A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure. Li G; Nottebaum AF; Brigell M; Navarro ID; Ipe U; Mishra S; Gomez-Caraballo M; Schmitt H; Soldo B; Pakola S; Withers B; Peters KG; Vestweber D; Stamer WD Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):12. PubMed ID: 33315051 [TBL] [Abstract][Full Text] [Related]
3. VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes. Siragusa M; Oliveira Justo AF; Malacarne PF; Strano A; Buch A; Withers B; Peters KG; Fleming I Cardiovasc Res; 2021 May; 117(6):1546-1556. PubMed ID: 32653904 [TBL] [Abstract][Full Text] [Related]
4. Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. Shen J; Frye M; Lee BL; Reinardy JL; McClung JM; Ding K; Kojima M; Xia H; Seidel C; Lima e Silva R; Dong A; Hackett SF; Wang J; Howard BW; Vestweber D; Kontos CD; Peters KG; Campochiaro PA J Clin Invest; 2014 Oct; 124(10):4564-76. PubMed ID: 25180601 [TBL] [Abstract][Full Text] [Related]
5. Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema. Campochiaro PA; Peters KG Curr Diab Rep; 2016 Dec; 16(12):126. PubMed ID: 27778249 [TBL] [Abstract][Full Text] [Related]
6. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. Goel S; Gupta N; Walcott BP; Snuderl M; Kesler CT; Kirkpatrick ND; Heishi T; Huang Y; Martin JD; Ager E; Samuel R; Wang S; Yazbek J; Vakoc BJ; Peterson RT; Padera TP; Duda DG; Fukumura D; Jain RK J Natl Cancer Inst; 2013 Aug; 105(16):1188-201. PubMed ID: 23899555 [TBL] [Abstract][Full Text] [Related]
7. Exploring the effect of inhibitor AKB-9778 on VE-PTP by molecular docking and molecular dynamics simulation. Liu WS; Wang RR; Sun YZ; Li WY; Li HL; Liu CL; Ma Y; Wang RL J Cell Biochem; 2019 Oct; 120(10):17015-17029. PubMed ID: 31125141 [TBL] [Abstract][Full Text] [Related]
8. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin. Frye M; Dierkes M; Küppers V; Vockel M; Tomm J; Zeuschner D; Rossaint J; Zarbock A; Koh GY; Peters K; Nottebaum AF; Vestweber D J Exp Med; 2015 Dec; 212(13):2267-87. PubMed ID: 26642851 [TBL] [Abstract][Full Text] [Related]
9. Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2. Drexler HCA; Vockel M; Polaschegg C; Frye M; Peters K; Vestweber D Mol Cell Proteomics; 2019 Oct; 18(10):2058-2077. PubMed ID: 31427368 [TBL] [Abstract][Full Text] [Related]
10. Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2. Campochiaro PA; Sophie R; Tolentino M; Miller DM; Browning D; Boyer DS; Heier JS; Gambino L; Withers B; Brigell M; Peters K Ophthalmology; 2015 Mar; 122(3):545-54. PubMed ID: 25439435 [TBL] [Abstract][Full Text] [Related]
14. Shear stress-induced redistribution of vascular endothelial-protein-tyrosine phosphatase (VE-PTP) in endothelial cells and its role in cell elongation. Mantilidewi KI; Murata Y; Mori M; Otsubo C; Kotani T; Kusakari S; Ohnishi H; Matozaki T J Biol Chem; 2014 Mar; 289(10):6451-6461. PubMed ID: 24451369 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Dominguez MG; Hughes VC; Pan L; Simmons M; Daly C; Anderson K; Noguera-Troise I; Murphy AJ; Valenzuela DM; Davis S; Thurston G; Yancopoulos GD; Gale NW Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3243-8. PubMed ID: 17360632 [TBL] [Abstract][Full Text] [Related]
16. Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation. Huo Z; Kong Y; Meng M; Cao Z; Zhou Q Vascul Pharmacol; 2019 Jun; 117():7-14. PubMed ID: 29894844 [TBL] [Abstract][Full Text] [Related]
17. VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Hayashi M; Majumdar A; Li X; Adler J; Sun Z; Vertuani S; Hellberg C; Mellberg S; Koch S; Dimberg A; Koh GY; Dejana E; Belting HG; Affolter M; Thurston G; Holmgren L; Vestweber D; Claesson-Welsh L Nat Commun; 2013; 4():1672. PubMed ID: 23575676 [TBL] [Abstract][Full Text] [Related]
18. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins. Mori M; Murata Y; Kotani T; Kusakari S; Ohnishi H; Saito Y; Okazawa H; Ishizuka T; Mori M; Matozaki T J Cell Physiol; 2010 Jul; 224(1):195-204. PubMed ID: 20301196 [TBL] [Abstract][Full Text] [Related]